U.S. Genomics Market Size & Outlook, 2023-2030
U.S. genomics market, 2018-2030 (US$M)
Related Markets
U.S. genomics market highlights
- The U.S. genomics market generated a revenue of USD 12,015.3 million in 2023 and is expected to reach USD 35,883.1 million by 2030.
- The U.S. market is expected to grow at a CAGR of 16.9% from 2024 to 2030.
- In terms of segment, functional genomics was the largest revenue generating application in 2023.
- Pathway Analysis is the most lucrative application segment registering the fastest growth during the forecast period.
Genomics market data book summary
| Market revenue in 2023 | USD 12,015.3 million |
| Market revenue in 2030 | USD 35,883.1 million |
| Growth rate | 16.9% (CAGR from 2023 to 2030) |
| Largest segment | Functional genomics |
| Fastest growing segment | Pathway Analysis |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Functional Genomics, Epigenomics, Pathway Analysis, Biomarker Discovery |
| Key market players worldwide | Agilent Technologies Inc, Bio-Rad Laboratories Inc, Danaher Corp, Eppendorf, Eurofins Scientific SE, Roche Holding AG ADR, GE Aerospace, Illumina Inc, Myriad Genetics Inc, Oxford Nanopore Technologies PLC, Pacific Biosciences of California Inc, Qiagen NV, Quest Diagnostics Inc, Thermo Fisher Scientific Inc, 23andMe Holding Co Class A |
Other key industry trends
- In terms of revenue, U.S. accounted for 36.8% of the global genomics market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. genomics market is projected to lead the regional market in terms of revenue in 2030.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 35,883.1 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Genomics Market Scope
Genomics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. genomics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to genomics market will help companies and investors design strategic landscapes.
Functional genomics was the largest segment with a revenue share of 32.19% in 2023. Horizon Databook has segmented the U.S. genomics market based on functional genomics, epigenomics, pathway analysis, biomarker discovery covering the revenue growth of each sub-segment from 2018 to 2030.
The U.S. is one of the largest markets for personalized medicine, owing to the need for rapid detection of chronic diseases such as cancer. Key market players in the region, such as Affymetrix and Illumina, are also focusing on agricultural genomics, which is anticipated to drive the market in the country.
Government organizations, such as NIH, fund a set of genome sequencing and analysis centers whose research focuses on understanding the genetic basis of rare and common human diseases. The strengthening of research efforts in genomics by government institutes is one of the factors supporting market growth.
In 2017, AWAKENS, Inc. launched a genomic explorer app in the U.S. market. It can enable users to access their whole genome data. Such initiatives are anticipated to propel the U.S. genomics market growth.
Reasons to subscribe to U.S. genomics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. genomics market databook
-
Our clientele includes a mix of genomics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. genomics market , including forecasts for subscribers. This country databook contains high-level insights into U.S. genomics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. genomics market size, by application, 2018-2030 (US$M)
U.S. Genomics Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
